Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.46
+0.20 (3.80%)
Nov 21, 2024, 11:58 AM EST - Market open
Serina Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Debt / Equity Ratio | -0.83 | 0.90 | -0.77 | 1.19 |
| Asset Turnover | 0.39 | 0.64 | 0.44 | - |
| Quick Ratio | 0.24 | 5.39 | 1.22 | 3.53 |
| Current Ratio | 0.40 | 5.39 | 1.25 | 3.58 |
| Return on Equity (ROE) | - | 594.21% | - | - |
| Return on Assets (ROA) | -86.74% | -39.79% | -105.01% | - |
| Return on Capital (ROIC) | -267.68% | -53.73% | -1390.61% | - |
| Buyback Yield / Dilution | 5.45% | -86.72% | -0.01% | - |
| Total Shareholder Return | 5.45% | -86.72% | -0.01% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.